These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 25683879)
1. How much potential for transient receptor potential channels in the bladder? Michel MC BJU Int; 2015 Mar; 115(3):350-1. PubMed ID: 25683879 [No Abstract] [Full Text] [Related]
2. Co-administration of transient receptor potential vanilloid 4 (TRPV4) and TRPV1 antagonists potentiate the effect of each drug in a rat model of cystitis. Charrua A; Cruz CD; Jansen D; Rozenberg B; Heesakkers J; Cruz F BJU Int; 2015 Mar; 115(3):452-60. PubMed ID: 25041193 [TBL] [Abstract][Full Text] [Related]
3. Carbenoxolone inhibits TRPV4 channel-initiated oxidative urothelial injury and ameliorates cyclophosphamide-induced bladder dysfunction. Zhang X; Gao S; Tanaka M; Zhang Z; Huang Y; Mitsui T; Kamiyama M; Koizumi S; Fan J; Takeda M; Yao J J Cell Mol Med; 2017 Sep; 21(9):1791-1802. PubMed ID: 28244642 [TBL] [Abstract][Full Text] [Related]
4. Effects of herpes simplex virus vectors encoding poreless TRPV1 or protein phosphatase 1α in a rat cystitis model induced by hydrogen peroxide. Takai S; Majima T; Reinhart B; Goins WF; Funahashi Y; Gotoh M; Tyagi P; Glorioso JC; Yoshimura N Gene Ther; 2018 Jan; 25(1):20-26. PubMed ID: 29057994 [TBL] [Abstract][Full Text] [Related]
5. Modulation of acute visceral nociception and bladder inflammation by plant triterpene, alpha, beta-amyrin in a mouse model of cystitis: role of tachykinin NK(1)-receptors, and K(+)(ATP) channels. Lima-Júnior RC; Sousa DI; Brito GA; Cunha GM; Chaves MH; Rao VS; Santos FA Inflamm Res; 2007 Dec; 56(12):487-94. PubMed ID: 18210232 [TBL] [Abstract][Full Text] [Related]
6. Re: Intravesical TRPV4 blockade reduces repeated variate stress-induced bladder dysfunction by increasing bladder capacity and decreasing voiding frequency in male rats. Atala A J Urol; 2015 Mar; 193(3):1060-1. PubMed ID: 25765429 [No Abstract] [Full Text] [Related]
7. GRC-6211, a new oral specific TRPV1 antagonist, decreases bladder overactivity and noxious bladder input in cystitis animal models. Charrua A; Cruz CD; Narayanan S; Gharat L; Gullapalli S; Cruz F; Avelino A J Urol; 2009 Jan; 181(1):379-86. PubMed ID: 19010489 [TBL] [Abstract][Full Text] [Related]
8. Discovery of potent transient receptor potential vanilloid 1 antagonists: design and synthesis of phenoxyacetamide derivatives. Takahashi E; Hirano N; Nagahara T; Yoshikawa S; Momen S; Yokokawa H; Hayashi R Bioorg Med Chem Lett; 2013 Jun; 23(11):3154-6. PubMed ID: 23632270 [TBL] [Abstract][Full Text] [Related]
9. Transient receptor potential vanilloid subfamily 1 is essential for the generation of noxious bladder input and bladder overactivity in cystitis. Charrua A; Cruz CD; Cruz F; Avelino A J Urol; 2007 Apr; 177(4):1537-41. PubMed ID: 17382774 [TBL] [Abstract][Full Text] [Related]
10. Re: Long-Term Ketamine Abuse Induces Cystitis in Rats by Impairing the Bladder Epithelial Barrier. Wein AJ J Urol; 2016 Jan; 195(1):222. PubMed ID: 26699996 [No Abstract] [Full Text] [Related]
11. Effect of partial and complete blockade of vanilloid (TRPV1-6) and ankyrin (TRPA1) transient receptor potential ion channels on urinary bladder motor activity in an experimental hyperosmolar overactive bladder rat model. Juszczak K; Ziomber A; Thor PJ J Physiol Pharmacol; 2011 Jun; 62(3):321-6. PubMed ID: 21893692 [TBL] [Abstract][Full Text] [Related]
12. The therapeutic role of sulfated polysaccharides in the urinary bladder. Parsons CL Urol Clin North Am; 1994 Feb; 21(1):93-100. PubMed ID: 7904388 [TBL] [Abstract][Full Text] [Related]
13. Improvement by phytotherapeutic agent of detrusor overactivity, down-regulation of pharmacological receptors and urinary cytokines in rats with cyclophosphamide induced cystitis. Nasrin S; Masuda E; Kugaya H; Ito Y; Yamada S J Urol; 2013 Mar; 189(3):1123-9. PubMed ID: 23000860 [TBL] [Abstract][Full Text] [Related]
14. Rat detrusor overactivity induced by chronic spinalization can be abolished by a transient receptor potential vanilloid 1 (TRPV1) antagonist. Santos-Silva A; Charrua A; Cruz CD; Gharat L; Avelino A; Cruz F Auton Neurosci; 2012 Jan; 166(1-2):35-8. PubMed ID: 22037502 [TBL] [Abstract][Full Text] [Related]
15. Sex differences in the expression profile of acid-sensing ion channels in the mouse urinary bladder: a possible involvement in irritative bladder symptoms. Kobayashi H; Yoshiyama M; Zakoji H; Takeda M; Araki I BJU Int; 2009 Dec; 104(11):1746-51. PubMed ID: 19493263 [TBL] [Abstract][Full Text] [Related]
16. Bladder afferent sensitivity in wild-type and TRPV1 knockout mice. Daly D; Rong W; Chess-Williams R; Chapple C; Grundy D J Physiol; 2007 Sep; 583(Pt 2):663-74. PubMed ID: 17627983 [TBL] [Abstract][Full Text] [Related]
17. Editorial Comment to Intravesical hyaluronic acid treatment improves bacterial cystitis and reduces cystitis-induced hypercontractility in rats. Damiano R; Cantiello F; Cicione A Int J Urol; 2015 Jun; 22(6):604. PubMed ID: 25808703 [No Abstract] [Full Text] [Related]
18. Cystitis is associated with TRPV1b-downregulation in rat dorsal root ganglia. Charrua A; Reguenga C; Paule CC; Nagy I; Cruz F; Avelino A Neuroreport; 2008 Oct; 19(15):1469-72. PubMed ID: 18797299 [TBL] [Abstract][Full Text] [Related]
19. The differential contractile responses to capsaicin and anandamide in muscle strips isolated from the rat urinary bladder. Saitoh C; Kitada C; Uchida W; Chancellor MB; de Groat WC; Yoshimura N Eur J Pharmacol; 2007 Sep; 570(1-3):182-7. PubMed ID: 17586490 [TBL] [Abstract][Full Text] [Related]
20. Use and limitations of three TRPV-1 receptor antagonists on smooth muscles of animals and man: a vote for BCTC. Benko R; Illényi L; Kelemen D; Papp R; Papp A; Bartho L Eur J Pharmacol; 2012 Jan; 674(1):44-50. PubMed ID: 22056835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]